Rana Al-Hrout/LinkedIn
Nov 19, 2026, 10:32
Rana Al-Hrout: The Hemodilution Trap – Accurate Blast Assessment in Bone Marrow Biopsies
Rana Al-Hrout, Clinical Pathology-Hematology Specialist at Ministry of Health – Jordan, shared a post on LinkedIn:
“Hematopathology Challenge: The Hemodilution Trap!
Case Scenario:
A hemodiluted bone marrow aspirate from a patient with suspected MDS with increased blasts (MDS-IB) shows 3% myeloblasts.
However, the corresponding bone marrow trephine biopsy demonstrates abnormal interstitial aggregates of CD34-positive cells with an increased overall CD34 plus cell burden.
What is the most appropriate approach to blast assessment in this case?
- Rely solely on the aspirate blast percentage.
- Use CD34 IHC to estimate blast burden, integrating with morphology and clinical context.
- Calculate the average percentage of both specimens.
- Disregard the biopsy findings entirely.”
Stay updated with Hemostatis Today.
-
Nov 19, 2026, 10:29Maria Panagiota Terzi: Presenting Research on Coagulation Biomarkers in Acute Myocardial Infarction
-
Nov 19, 2026, 10:21Paola Ranalli: Hemophilia and von Willebrand Disease Advancing Care Through Multidisciplinary Collaboration
-
Nov 19, 2026, 10:11Rana Al-Hrout: Iron Deficiency in Heart Failure – Does It Matter Even Without Anemia?
-
Nov 19, 2026, 10:08Christina Rolling: CAR T-Cell Therapy and Coagulation Disturbances Understanding Severe Hypofibrinogenemia
-
Nov 19, 2026, 09:34Dahlia R.: Immature Platelet Fraction Understanding the Cause of Low Platelet Counts
-
Nov 19, 2026, 07:00Rucha Patil: Highlights in Science and Collaboration at Haematocon 2026
-
Nov 19, 2026, 06:20Suvro Sankha Datta: AABB Releases the 8th Edition of Molecular Testing Standards
-
Nov 19, 2026, 05:54Global Collaboration in Hemostasis – ISTH
-
Nov 19, 2026, 05:40Pete Stibbs: Advancing Treatment Strategies in Venous Disease